BeiGene, Ltd. 4
4 · BeiGene, Ltd. · Filed Apr 21, 2017
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Yi Qingqing
Director
Transactions
- Award
Share Option (Right to Buy)
2017-04-19+199,992→ 199,992 totalExercise: $2.84Exp: 2027-04-18→ Ordinary Shares (199,992 underlying)
Footnotes (2)
- [F1]In ordinary shares. One American Depositary Share represents 13 ordinary shares.
- [F2]The option shall become exercisable in equal installments on the first, second and third anniversary of the grant date and shall become exercisable in full on the date of the third annual meeting of shareholders following the grant date. All vesting shall cease if the Reporting Person resigns from the Issuer's board of directors or otherwise ceases to serve as a director, unless the Issuer's board of directors determines that the circumstances warrant the continuation of vesting.